Patients expressing these mutations oftentimes have transient neonatal hyperinsulinemia hypoglycemia, progressive hypoglycemia throughout childhood, gradual decrease in insulin secretion, and diagnosis with diabetes mellitus before the age of 25 [8,138,139]. Here, INS is linked to Hypoglycemia.